DHA-PIP

DRUG2 trials

Sponsors

Armed Forces Research Institute of Medical Sciences, Thailand, University of Oxford

Conditions

MalariaMalaria,FalciparumParasitic Diseases

Phase 2

Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults

CompletedNCT05252845

University of OxfordMalaria,Falciparum

Start: 2023-01-04End: 2023-09-18Updated: 2025-07-03

Phase 4

Malaria Elimination Pilot Study in Military Forces in Cambodia

Armed Forces Research Institute of Medical Sciences, ThailandMalaria, Parasitic Diseases

Start: 2016-01-31End: 2021-12-31Updated: 2021-03-02

Related Papers

Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia

UNC Libraries2020-06-26

Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia

UNC Libraries2019-08-18

Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia.

2018-10-167 citations